A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.

Yongfeng YuWen DongYanxia ShiRong WuQitao YuFeng YeChengzhi ZhouXiaorong DongXingya LiYongsheng LiZhen LiLin WuYueyin PanHong ShenDehua WuZhongyuan XuJinsheng WuNong XuYanru QinAimin ZangJingdong ZhangJianya ZhouXiaotao ZhangYanqiu ZhaoFugen LiHuizhen WangQi LiuZhenyong HanJin LiShun Lu

Published in: Therapeutic advances in medical oncology (2024)

ClinicalTrials.gov identifier: NCT03457532; NCT04270591.

Keyphrases

cell proliferation
copy number
genome wide
tyrosine kinase
transcription factor
genome wide identification
gene expression
newly diagnosed
dna methylation
genome wide analysis